Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis
Severe Acute Respiratory Syndrome Coronavirus 2 Aspergillosis Invasive Isavuconazole Antifungal Agents Anti-infective Agents Coronavirus-associated Invasive Pulmonary Aspergillosis CAPA Aspergillosis Pulmonary Aspergillosis Coronavirus Infections Severe Acute Respiratory Syndrome Isavuconazonium Injection [Cresemba]
Lead Scientists at UC Health
- Jeffrey Jenks, MD, MPH (ucsd)
Assistant Clinical Professor, Medicine. Authored (or co-authored) 39 research publications. Research interests: Clinical mycology · Fungal diagnostics · Rare fungal infections · Spectrum of tuberculosis infection.
- George Thompson, MD (ucdavis)
Associate Professor, Infectious Diseases. Authored (or co-authored) 144 research publications.
- Martin Hoenigl, MD (ucsd)
Associate Professor, Medicine. Authored (or co-authored) 230 research publications.
- accepting new patients
- Start Date
- Completion Date
- Jeffrey Jenks, MD, MPH
- Phase 3
- Study Type
- Last Updated